Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma (THBC-HSL2)

Hospital Sirio-Libanes

Status: Completed

Conditions: Hepatitis; Hepatocellular Carcinomas

Treatments: Device: Low intensity amplitude-moduled electromagnetic fields

Study type: Interventional

Funder types: Other

Identifiers

NCT01641276

02621512.3.0000.5461

Details and patient eligibility

About

The propose of this study is to identification of a group of specific amplitude-modulated frequencies of low intensity electromagnetic fields that is associated with biofeedback upon exposure to in patients with hepatitis B carries with or without hepatocellular carcinoma.

Full description

Patients will be exposed by different specific amplitude-modulated frequencies of low intensity electromagnetic fields for 30 min. During the exposure, autonomic response with be recorded in order to identify biofeedback response. Differences in group of frequencies is expected in patients with hepatitis B carries with or without hepatocellular carcinoma.

Enrollment: 60 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• hepatitis B carriers patients
• hepatitis B carriers patients with hepatocellular cancer patients

Exclusion criteria

• other tumor types
• other hepatitis types

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

60 participants in 2 patient groups

hepatitis

Experimental group

Description:

hepatitis B carriers patients

Treatment:

Device: Low intensity amplitude-moduled electromagnetic fields

hepatocellular carcinoma patients

Experimental group

Description:

hepatites B carriers patients with associated hepatocellular carcinoma

Treatment:

Device: Low intensity amplitude-moduled electromagnetic fields